Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1962 Jul;24(4):422–430. doi: 10.1136/hrt.24.4.422

MECHANISM OF PULMONARY VASOCONSTRICTION AFTER INJECTION OF 5-HYDROXYTRYPTAMINE IN THE DOG

E Vitolo 1, M Obbiassi 1, G P Zocche 1, G C Scotti 1
PMCID: PMC1017902  PMID: 13926301

Full text

PDF
422

Images in this article

427Image
on p.427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATTINGER E. O. Some interrelations between ventilation and circulation. Am Heart J. 1957 Dec;54(6):837–850. doi: 10.1016/0002-8703(57)90189-8. [DOI] [PubMed] [Google Scholar]
  2. BALCHUM O. J., GENSINI G., BLOUNT S. G., Jr The effect of hexamethonium upon the pulmonary vascular resistance in mitral stenosis. J Lab Clin Med. 1957 Aug;50(2):186–198. [PubMed] [Google Scholar]
  3. BORST H. G., BERGLUND E., MCGREGOR M. The effects of pharmacologic agents on the pulmonary circulation in the dog; studies on epinephrine, nor-epinephrine, 5-hydroxytryptamine, acetylcholine, histamine and aminophylline. J Clin Invest. 1957 May;36(5):669–675. doi: 10.1172/JCI103467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BORST H. G., MCGREGOR M., WHITTENBERGER J. L., BERGLUND E. Influence of pulmonary arterial and left atrial pressures on pulmonary vascular resistance. Circ Res. 1956 Jul;4(4):393–399. doi: 10.1161/01.res.4.4.393. [DOI] [PubMed] [Google Scholar]
  5. BRACCO M., CURTI P. C. La 5-ossitriptamina enteramina-serotonina. Recenti Prog Med. 1958 Nov;25(5):425–459. [PubMed] [Google Scholar]
  6. CARLIER J., LEJEUNE-LEDANT G., BARAC G. Angiotensine, 5-hydroxytryptamine et circulation pulmonaire chez le chien. C R Seances Soc Biol Fil. 1958;152(6):1034–1038. [PubMed] [Google Scholar]
  7. DAVIES L. G., GOODWIN J. F., VAN LEUVEN B. D. The nature of pulmonary hypertension in mitral stenosis. Br Heart J. 1954 Oct;16(4):440–446. doi: 10.1136/hrt.16.4.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FOWLER N. O., WESTCOTT R. N., HAUENSTEIN V. D., SCOTT R. C., McGUIRE J. Observations on autonomic participation in pulmonary arteriolar resistance in man. J Clin Invest. 1950 Oct;29(10):1387–1396. doi: 10.1172/JCI102376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FREIS E. D., ROSE J. C., PARTENOPE E. A., HIGGINS T. F., KELLEY R. T., SCHNAPER H. W., JOHNSON R. L. The hemodynamic effects of hypotensive drugs in man. III. Hexamethonium. J Clin Invest. 1953 Dec;32(12):1285–1298. doi: 10.1172/JCI102857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GILBERT R. P., HINSHAW L. B., KUIDA H., VISSCHER M. B. Effects of histamine, 5 hydroxytryptamine and epinephrine on pulmonary hemodynamics with particular reference to arterial and venous segment resistances. Am J Physiol. 1958 Jul;194(1):165–170. doi: 10.1152/ajplegacy.1958.194.1.165. [DOI] [PubMed] [Google Scholar]
  11. GILMORE H. R., KOPELMAN H., MCMICHAEL J., MILNE I. G. The effect of hexamethonium bromide on the cardiac output and pulmonary circulation. Lancet. 1952 Nov 8;2(6741):898–902. doi: 10.1016/s0140-6736(52)91272-5. [DOI] [PubMed] [Google Scholar]
  12. GINZEL K. H., KOTTEGODA S. R. A study of the vascular actions of 5-hydroxytryptamine, tryptamine, adrenaline and noradrenaline. Q J Exp Physiol Cogn Med Sci. 1953;38(4):225–231. doi: 10.1113/expphysiol.1953.sp001033. [DOI] [PubMed] [Google Scholar]
  13. GOMEZ FERRER BAYO F. Ei factor vascular en la embolia pulmonar. Med Esp. 1958 Aug;40(233):125–140. [PubMed] [Google Scholar]
  14. KABINS S. A., MOLINA C., KATZ L. N. Pulmonary vascular effects of serotonin (5-OH-tryptamine) in dogs: its role in causing pulmonary edema. Am J Physiol. 1959 Nov;197:955–958. doi: 10.1152/ajplegacy.1959.197.5.955. [DOI] [PubMed] [Google Scholar]
  15. MACCANON D. M., HORVATH S. M. Some effects of serotonin in pentobarbital anesthetized dogs. Am J Physiol. 1954 Oct;179(1):131–134. doi: 10.1152/ajplegacy.1954.179.1.131. [DOI] [PubMed] [Google Scholar]
  16. MACKINNON J., VICKERS C. F., WADE E. G. The nature of the increased pulmonary vascular resistance in mitral stenosis. Br Heart J. 1956 Oct;18(4):458–466. doi: 10.1136/hrt.18.4.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. NAHAS G. G., MACDONALD I. Effects of norepinephrine and 5-hydroxytryptamine on the pulmonary circulation of the spinal dog. Am J Physiol. 1959 May;196(5):1045–1048. doi: 10.1152/ajplegacy.1959.196.5.1045. [DOI] [PubMed] [Google Scholar]
  18. NAHAS G. G. Reactions vaso-motrices de la circulation pulmonaire chez le chien spinal. J Physiol (Paris) 1958 Mar;50(2):425–428. [PubMed] [Google Scholar]
  19. PAGE I. H. The vascular action of natural serotonin, 5- and 7-hydroxytryptamine and tryptamine. J Pharmacol Exp Ther. 1952 May;105(1):58–73. [PubMed] [Google Scholar]
  20. PATON W. D. M., ZAIMIS E. J. The pharmacological actions of polymethylene bistrimethyl-ammonium salts. Br J Pharmacol Chemother. 1949 Dec;4(4):381–400. doi: 10.1111/j.1476-5381.1949.tb00565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. ROSE J. C., LAZARO E. J. Pulmonary vascular responses to serotonin and effects of certain serotonin antagonists. Circ Res. 1958 May;6(3):283–288. doi: 10.1161/01.res.6.3.283. [DOI] [PubMed] [Google Scholar]
  22. RUDOLPH A. M., PAUL M. H. Pulmonary and systemic vascular response to continuous infusion of 5-hydroxytryptamine (serotonin) in the dog. Am J Physiol. 1957 May;189(2):263–268. doi: 10.1152/ajplegacy.1957.189.2.263. [DOI] [PubMed] [Google Scholar]
  23. SANCETTA S. M. Acute hemodynamic effects of hexamethonium (C6) in patients with emphysematous pulmonary hypertension. Am Heart J. 1955 Apr;49(4):501–506. doi: 10.1016/0002-8703(55)90069-7. [DOI] [PubMed] [Google Scholar]
  24. SHEPHERD J. T., DONALD D. E., LINDER E., SWAN H. J. Effect of small doses of 5-hydroxytryptamine (serotonin) on pulmonary circulation in the closed-chest dog. Am J Physiol. 1959 Nov;197:963–967. doi: 10.1152/ajplegacy.1959.197.5.963. [DOI] [PubMed] [Google Scholar]
  25. STORSTEIN O., TVETEN H. The effect of hexamethonium bromide on the pulmonary circulation. Scand J Clin Lab Invest. 1954;6(3):169–177. [PubMed] [Google Scholar]
  26. THIEBLOT L., DUCHENE-MARULLAZ P., BERTHELAY J. Effet sur la pression artérielle du Chien amyélé de la 5 hydroxytryptamine (sérotonine). C R Seances Soc Biol Fil. 1957;151(1):34–35. [PubMed] [Google Scholar]
  27. WAKIM K. G. Certain cardiovasculorenal effects of hexamethonium. Am Heart J. 1955 Sep;50(3):435–441. doi: 10.1016/0002-8703(55)90164-2. [DOI] [PubMed] [Google Scholar]
  28. WALDENSTROM J., LJUNGBERG E. Studies on the functional circulatory influence from metastasizing carcinoid (argentaffine, enterochromaffine) tumours and their possible relation to enteramine production. I. Symptoms of cardinoidosis. Acta Med Scand. 1955 Nov 10;152(4):293–309. doi: 10.1111/j.0954-6820.1955.tb03490.x. [DOI] [PubMed] [Google Scholar]
  29. YU P. N., NYE R. E., Jr, LOVEJOY F. W., Jr, SCHREINER B. F., YIM B. J. Studies of pulmonary hypertension. IX. The effects of intravenous hexamethonium on pulmonary circulation in patients with mitral stenosis. J Clin Invest. 1958 Feb;37(2):194–201. doi: 10.1172/JCI103598. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES